Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria
β Scribed by Ashkan Emadi; Robert A. Brodsky
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 229 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hemolytic anemia caused by somatic mutations in the phosphatidylinositol glycan-complementation class A gene and the resulting absence of a key complement regulatory protein, CD59. Affected red blood cells in patients with PNH undergo int
## Abstract Paroxysmal nocturnal hemoglobinuria (PNH) is a debilitating and lifeβthreatening disease in which lysis of PNH red blood cells frequently manifests with chronic hemolysis, anemia, and thrombosis. Renal damage in PNH is associated with chronic hemosiderosis and/or microvascular thrombosi
Recurrent venous thrombosis following liver transplantation for Budd-Chiari syndrome is common, particularly in the setting of an underlying myeloproliferative disorder. We describe a patient who developed refractory ascites due to portal vein thrombosis following liver transplantation for Budd-Chia
The relationships between paroxysmal nocturnal hemogloblnuria (PNH), aplastlc anemia (AA), and myelodysplastlc syndrome (MDS) are not clear. Here we describe a patient, J20, who developed a reciprocal translocation of chromosome 12 and PNH during follow-up of AA. All metaphases In CD59-deflcient bon